To investigate safety and eficacy of yishumei--a injectable cross-linked sodium hyaluronate gel on alleviating moderate and severe nasolabial groove.
Methods A randomized,single-blind,parallel controlled study was conducted on selected volunteers with moderate and severe nasolabial groove.Restylane" ll or yishumei"(<1.5 ml)was injected either side to correct nasolabial groove.Bilateral nasolabial wrinkle severity rating scale (WSRS)and adverse events were evaluated by surgeon and volunteers independently at preoperative and immediately,4 weeks,12 weeks,24 weeks after procedure.SPSS13.0 software was used for statistical analysis.
Results The average age of 30 selected volunteers(28 female,2 male)was 45.8.Bilateral nasolabial WSRS declined after procedure,and the difference between
WSRS of immediately and of 24 weeks later has no statistically significance(P>0.05).Two cases of adverse events (2/30,6.67%)occurred during the test,and one case thought to be related to the research materials.
Reference From Journal of Practical Dermatology,Feb.2016 ,Vol.9,No.1
Writer:
ZHOU Zhi qiang,SUI Zhi fu,LIU Chang,et al
Institute of Skin Damage and Repair,GeneralHospital ofBeijing M ilitary Com mand,Beijing 100700,China
-
singclean | 2017-08-17Singclean Medical Shines at Medica 2024: New Products Worldwide Launch Receives High PraiseSingclean Medical successfully participated in the Medica 2024 exhibition.
-
singclean | 2017-08-17Singclean Medical is about to shine at Medica 2024: a medical feast of innovation and cooperationThe highly anticipated Medica 2024 exhibition in the medical industry will kick off in Düsseldorf, Germany on November 11, 2024. Singclean Medical will appear with many exciting contents, bringing new vitality and surprises to the global medical community.
-
singclean | 2017-08-17Singclean Medical shines at industry events, leading the new trend of medical beautyRecently, Singclean Medical, a world-leading medical beauty solution provider, attracted widespread attention in the industry with its two star products, Singfiller and Singderm, at CIRA 2024 (Oriental Aesthetics and Integrative Rejuvenation Conference) and the 2024 Zhejiang Provincial Medical Association·Aesthetic and Plastic Surgery Conference.